A Safety Study of Liposomal Cyclosporine A to Treat Bronchiolitis Obliterans Syndrome Following Allogeneic Hematopoietic Stem Cell Transplant
Conditions: Bronchiolitis Obliterans; GVHD, Chronic; Stem Cell Transplant Complications Interventions: Drug: Liposomal Cyclosporine A; Drug: Liposomal Placebo Sponsor: Breath Therapeutics Inc. Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: Bronchiolitis | Research | Restasis | Stem Cell Therapy | Stem Cells | Study | Transplants